Chaim Lebovits - 20 Apr 2023 Form 4 Insider Report for BRAINSTORM CELL THERAPEUTICS INC. (BCLI)

Role
President & Co-CEO
Signature
/s/ Chaim Lebovits
Issuer symbol
BCLI
Transactions as of
20 Apr 2023
Net transactions value
$0
Form type
4
Filing time
24 Apr 2023, 06:44:08 UTC
Previous filing
04 Jan 2023
Next filing
04 Aug 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BCLI Common Stock Award $0 +75,000 +40% $0.000000 262,110 20 Apr 2023 Direct F1
holding BCLI Common Stock 2,000,847 20 Apr 2023 See footnote F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares acquired are shares of restricted stock awarded under the Issuer's 2014 Stock Incentive Plan. The shares were fully vested upon grant.
F2 Includes (i) 1,933,794 shares of Common Stock owned by ACCBT Corp. and (ii) 67,053 shares of Common Stock owned by ACC International Holdings Ltd. Reporting Person may be deemed the beneficial owner of these shares.